FDC
Back to Balance Sheet
|
FDC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹108 Cr | ₹74 Cr | ₹60 Cr | ₹56 Cr | ₹38 Cr |
What is the latest Contingent Liabilities ratio of FDC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹108 Cr |
| Mar2024 | ₹74 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹56 Cr |
| Mar2021 | ₹38 Cr |
How is Contingent Liabilities of FDC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹108 Cr | 44.57 | |
| Mar2024 | ₹74 Cr | 24.95 | |
| Mar2023 | ₹60 Cr | 5.77 | |
| Mar2022 | ₹56 Cr | 48.30 | |
| Mar2021 | ₹38 Cr | - | |
Compare Contingent Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,308.5 Cr | -4.6% | -9.1% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -2.6% | 2.4% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹221,666.0 Cr | 6.5% | 23.3% | 25.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,108.0 Cr | 2.6% | 3% | 33.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.1% | -0.2% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,990.9 Cr | 2.6% | -13.3% | -10.7% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -4.6% |
-9.1% |
-17.2% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses